Major Program
NCI Community Oncology Research Program
Research Group
Community Oncology and Prevention Trials
Sponsor
University of Rochester NCORP Research Base
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05364086
This study compares treatment outcomes between patients of African American/Black (AA)
ancestry and European American/White (EA) ancestry currently receiving immune checkpoint
inhibitor treatment. Collecting samples of blood and saliva and health and treatment
information from racially diverse patients receiving immune checkpoint inhibitor treatment
over time may help doctors better understand health care disparities among all cancer
patients.
ancestry and European American/White (EA) ancestry currently receiving immune checkpoint
inhibitor treatment. Collecting samples of blood and saliva and health and treatment
information from racially diverse patients receiving immune checkpoint inhibitor treatment
over time may help doctors better understand health care disparities among all cancer
patients.
Condition
Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Investigators
Charles S Kamen, PhD, Song Yao, PhD, Jay W. Carlson, Bryan A. Faller